Autonomix Medical (AMIX) Proxy filing summary

Executive summary

• Annual Meeting scheduled for October 17, 2024, at the company's principal executive offices.

• Shareholders of record as of August 26, 2024, are eligible to vote on key proposals.

• Proxy materials are available online, with paper copies upon request, supporting environmental and cost-saving initiatives.

Voting matters and shareholder proposals

• Election of five Board nominees to serve until the 2025 annual meeting.

• Ratification of Forvis Mazars, LLP as independent auditor for the fiscal year ending March 31, 2025.

• Approval of an amendment to authorize the Board to effect a reverse stock split at a ratio between 1-for-2 and 1-for-50 within one year.

• Board recommends voting FOR all proposals.

Board of directors and corporate governance

• Board consists of six members, with five nominated for re-election.

• Majority of directors are independent under Nasdaq rules; only Ms. Bisson and Mr. Klemp are not.

• Board committees include Audit, Compensation, and Nominating and Corporate Governance, each with independent members.

• Board diversity matrix shows one female and four male directors, with one Asian and four White members.

• Board held one meeting in fiscal 2024; all directors attended over 75% of meetings.